Additionally, one-way logistic regression analysis of the significantly different variables showed that HER2 status, tumor size, radiotherapy, chemotherapy, surgical treatment, and TN staging may be risk factors for the development of cancer metastasis in patients with IDC. The gene discussed is ERBB2; the disease is neoplasm.